Business
Presenting at Canaccord Genuity Growth Conference
Presenting at Canaccord Genuity Growth Conference.
About this update from Diaceutics Plc
[{"type":"text","content":"\n\nDiaceutics Presenting at Canaccord Genuity 44th Annual Growth Conference\n\nBelfast and London, 5 August 2024 - Diaceutics PLC (AIM: DXRX), a leading technology and solutions provider to the pharma and biotech industry today announces that management will attend and present at the Canaccord Genuity 44th Annual Growth Conference taking place on August 13-15, 2024 in Boston, MA.\nThe Conference brings together investors from around the world with some of the best and most promising growth companies in Canaccord's core sectors - Technology, Healthcare, Digital & Tech-Enabled Health, Sustainability, Industrials, and Consumer & Retail. For more information please click here. \nEnquiries: \n \n\n\n\n\nDiaceutics PLC \n\n\n\n\n\n\n\nRyan Keeling, Chief Executive Officer \nNick Roberts, Chief Financial Officer \n\n\nTel: +44 (0)28 9040 6500\[email protected]\n \n\n\n\n\n\n\n\n\n\n\n\n\nStifel Nicolaus Europe Limited (Nomad & Broker)\n\n\nTel: +44 (0)20 7710 7600\n\n\n\n\nBen Maddison, Nick Harland, Kate Hanshaw\n\n\n\n\n\n\n\n \nAlma Strategic Communications\n\n\n \nTel: +44(0)20 3405 0205 \n\n\n\n\nCaroline Forde, Kinvara Verdon\n \n\n\[email protected]\n \n\n\n\n\n \nAbout Diaceutics\nAt Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome.\n \nWe provide the world's leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX - The Diagnostics Network ®.\n\n","length":4756,"tagName":"div"}]